Gene Therapy Market Research Reports & Industry Analysis
Gene therapy is an innovative field with the potential to develop new, personalized medical treatments for previously challenging conditions. At MarketResearch.com, we are committed to providing you with comprehensive gene therapy industry reports that shed light on this fast-growing market.
Understanding the Gene Therapy Market
- Our gene therapy market research reports provide valuable insights into this dynamic field to help you understand the key factors at play, prepare for challenges, and leverage technological advancements.
- Our research collection covers various markets—such as gene therapy, precision medicine, delivery devices, and manufacturing services—with data on market size and growth projections.
- In addition, we also delve into market segmentation, key developments, industry trends, and company profiling to give you the full picture of the market.
Helping You Stay Ahead
Whether you're an experienced industry professional, a consultant, or a busy executive, our gene therapy market research reports provide valuable insights. These reports are based on reliable data and expert analysis to help you make informed business decisions. With MarketResearch.com, you can stay ahead of the competition and take advantage of emerging market opportunities.
Gene Therapy Industry Research & Market Reports
-
Primary Cell Culture Market Size, Share, and Outlook, 2025 Report- By Product (Primary Cells, Reagents and Supplements, Media), By Separation Method (Explant Method, Enzymatic Degradation, Mechanical Separation, Others), By Type (Animal Cells, Human Cells), By Application (Cell & Gene Therapy Development, Vaccine Production, Model System, Virology, Prenatal Diagnosis, Others), 2021-2032
... poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Primary Cell Culture segments across 22 countries ... Read More
-
Viral Vector Market Size, Share, and Outlook, 2025 Report- By Type (Adeno-associated virus (AAV), Adenovirus, Lentivirus, Retrovirus, Others), By Application (Cell & Gene Therapy, Vaccine, Biopharmaceutical & Pharmaceutical Discovery), By End-user (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, CROs & CMOs), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Viral Vector segments across 22 countries from 2021 to 2032. ... Read More
-
Red Biotechnology Market Size, Share, and Outlook, 2025 Report- By Product (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Proteins, Vaccines, Cell-Based Immunotherapy Products, Gene Therapy Products, Cell Therapy Products, Tissue-Engineered Products, Stem Cells, cell culture, Viral Vector, Enzymes, Kits and Reagents, Animal models, Molecular diagnostics, Others), By End-user (Academic Research Institutes, CMOs & CROs, Pharmaceutical & Biotechnology Companies, Others), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Red Biotechnology segments across 22 countries from 2021 to 2032. ... Read More
-
DNA Methylation Market Size, Share, and Outlook, 2025 Report- By Technology (Polymerase Chain Reaction (PCR), Microarray, Sequencing, Other), By Product (Consumables, Kits & Reagents, Enzymes, Instrument and Software), By Application (Gene Therapy, Clinical Research, Diagnostics, Others), By End-User (Hospital & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Research & Academia, New England Biolabs), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on DNA Methylation segments across 22 countries from 2021 to 2032. ... Read More
-
Serum-free Media Market Size, Share, and Outlook, 2025 Report- By Product (Classical Media, Specialty Media, Stem Cell Media, Others), By End-user (Biopharmaceutical Companies, Contract Research Organizations, Academic and Research Institutes, Others), By Application (Bioproduction, Vaccine Production, Cell and Gene Therapy, Tissue Engineering and Regenerative Medicine, Others), By Animal Origin, Animal-derived Serum-Free Media, Plant-derived Serum-Free Media, Synthetic Serum-Free Media), By Distribution Channel (Direct Sales, Distributor), 2021-2032
... growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Serum-free Media segments across 22 countries from 2021 to 2032. ... Read More
-
Targeted Drug Delivery Device Market (2nd Edition): Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Device (Catheters, Cannulas and Others), Target Organ (Brain, Breast, Eyes and Heart), Type of Therapy Delivered (Cell Therapies, Gene Therapies and Immunotherapies), Route of Administration (Intratumoral, Transendocardial and Others), Therapeutic Area (Cardiovascular Disorders, Oncological Disorders, Ophthalmic Disorders and Neurological Disorders) and Key Geographical Regions (North America, Europe and Asia-Pacific), and Leading Players and Sales Forecast
... CAGR of 19.7% during the forecast period, till 2035. The opportunity for targeted drug delivery device market has been distributed across the following segments: Type of Device Cannula Catheter Others Type of Organ Brain Breast ... Read More
-
Europe Contract Research Organization Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type (Early Phase Development Services, Clinical Research Services, Laboratory Services, and Post-Approval Services), Product type (Cell and Gene Therapy, Biosimilars, Antibody Drug Conjugates, and Others), Type (In-house and Outsource), Application (Oncology, Neurology, Cardiology, Infectious Diseases, Metabolic Disorder, Nephrology, Respiratory, Dermatology, Ophthalmology, Hematology and Others), and End User (Pharmaceutical and Biotech Companies, Medical Device Companies, and Academic and Research Institutes)
... 2031. The Europe Contract Research Organization market forecast presented in this report can help stakeholders in this marketplace plan their growth strategies. The Increased outsourcing of R&D and rising demand for clinical trials are the ... Read More
-
Cell & Gene Therapies in CNS Disorders - Update
... gene-modified cell therapies, and three conditionally approved cell therapies. Novartis’s Zolgensma (onasemnogene abeparvovec) for the treatment of spinal muscular atrophy (SMA) was the first CGT asset to receive traditional approval in the CNS market in ... Read More
-
Global Primary Cell Culture Market, By Product Type (Primary Cells, Instruments, Reagents and Supplements, Media, Other Consumables), By Cell Type (Human Primary Cells, Animal Primary Cells,), By Application (Cell & Gene Therapy Development, Vaccine Production, Drug Discovery and Development, Cancer Research, Prenatal Diagnosis, Others), By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Contract Research Organizations (CROs), Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... environment. Primary cell culture maintains the differentiated state of the cells since they are obtained directly from tissues, unlike secondary cell culture obtained from already established immortal cell lines. Primary cell culture plays a crucial ... Read More
-
Spinal Muscular Atrophy Market, by Type (Type I, Type II, Type III, and Type IV), by Treatment (Gene Therapy and Disease-modifying drugs), by Age Group (Infant and Adult), by Route of Administration (Oral and Injectables), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032
... impulses from the nerve cells. Atrophy is the medical term for shrinking, which is what muscles do when they are not stimulated by nerve cells. SMA is a motor neuron disease that includes the loss ... Read More
-
Gene Therapy Global Market Report 2025
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Cell and Gene Therapy Global Market Report 2025
... gene therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly ... Read More
-
2025 Global Cell And Gene Therapy Clinical Trials Industry (2031 Outlook)
... size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, market ... Read More
-
Cell And Gene Therapy Supply Chain/Logistics Global Market Report 2025
... cell and gene therapy supply chain/logistics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to ... Read More
-
Cell & Gene Therapy Manufacturing Services Global Market Report 2025
... cell & gene therapy manufacturing services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to ... Read More
-
Barth Syndrome Treatment Market, By Therapeutic Approaches (Enzyme Replacement Therapy, Gene Therapy, Supportive Care, Stem Cell Therapy, and Others (Small Molecule Drugs)), By Drug Classes (Cardiolipin Precursors, Antioxidants, Immunomodulators, Antibiotics, Dietary Supplements, and Others), By Route of Administration (Oral, Intravenous, and Others (Intramuscular and Topical)), By End User (Hospitals, Specialty Clinics, Research Institutions, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... is mutations in the TAZ gene affecting mitochondrial function and leading to structural abnormalities. Currently, there is no cure for the condition and treatment focuses on managing symptoms and improving quality of life. Increasing research ... Read More
-
Global Cancer Therapeutics And Biotherapeutics Market, By Application (Blood Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Breast Cancer, Cervical Cancer, Head and Neck Cancer, Giloblastoma, Malignant Meningioma, Mesothelioma, Melanoma, and Others), By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Hormone Therapy, Biotherapy, and Others), By Application (Therapeutics, Drug Discovery, Gene therapy, IVF treatment, Cell therapy, and Research & Development), By End User (Hospitals & Clinics, Cancer Care Centers, Research Institutes, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... the human immune system or block cancer cell growth using monoclonal antibodies or other agents. Targeted cancer therapies focus on specific molecular targets found in cancer cells unlike chemotherapy which affects all rapidly dividing normal ... Read More
-
Global Cell and Tissue Preservation Market, By Type (Cell (Mammalian Cells, Others (Microorganisms and Plant Cells)), Tissue (Blood, Bone, Soft Tissues, Skin)), By Product (Equipments (Kits & Reagents, Freezers & Refrigerators, Storage Systems, Others), Software, Bio-preservation Media, Home-brew Media , Pre-formulated Media), By Application (Therapeutics, Drug Discovery, Gene therapy, IVF treatment, Cell therapy, Research & Development), By End User (Biobanks & Cell banks, Hospitals & Diagnostics Labs, Research Laboratories, Others), By Preservation Technique (Cryopreservation, Ambient Temperature Storage, Temperature-controlled Storage, Drying / Freeze-Drying, Radiation , Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... cells and tissues outside the living organism. Growing stem cell research and growing demand for biobanking can boost demand for cell and tissue preservation techniques and technologies. Advancements in fields like regenerative medicine, tissue engineering ... Read More
-
CRDMO Market - Global Outlook & Forecast 2024-2029
... In 2023, Lonza expanded its CRDMO capabilities by opening a new development and manufacturing facility dedicated to cell and gene therapies, enhancing support for advanced therapeutic modalities. Catalent, a prominent CRDMO, launched a comprehensive suite ... Read More
-
Gene Therapy Market by Type (Gene silencing), Vector (Viral (Retroviral, AAV), Non-viral (Oligonucleotide)), Gene Type (Receptors, Cytokine), Therapeutic Area (Oncology, Neurology), Delivery Method (In-Vivo, Ex-Vivo), RoA (IV) - Global Forecast to 2032
... of the gene therapy market has been significantly driven by increasing R&D investment by key players for the development gene therapy drugs and growing approval of novel gene therapies. However, complex regulatory frameworks and ethical ... Read More
-
Cell and Gene Therapy Market Deals: Investment, M&A, and Partnerships, 2021-2025 (3rd Edition)
... thrive. Whether you are a biotech executive, investor, R&D leader, or regulatory strategist, this report provides data-driven insights to inform your next move. TWO REPORTS FOR THE PRICE OF ONE Cell and Gene Therapy Market ... Read More
-
Recombinant Dna Technology Market, By Product Type (Recombinant Protein Drugs, Vaccines , Genetically Modified Crops, Cell and Gene Therapy, and Gene Editing), By Application (Therapeutics, Agriculture, Research, and Others), By End User (Biotechnology and Pharmaceutical Company, Diagnostic Laboratories, Academic and Government Institutes, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... joining together of DNA molecules from two different sources into one molecule that can replicate and direct the assembly of its own components or related proteins. This process involves physically combining and interweaving two different ... Read More
-
Cell Culture Market, By Product (Consumables, Instruments), By Application (Biopharmaceutical Production, Tissue Culture & Engineering, Toxicity Testing, Drug Development, Cell & Gene Therapy, and Others), By End User (Biopharmaceutical Companies, Hospitals & Diagnostic Laboratories, CMO & CRO, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... seen significant growth in the last few decades driven by advancements in biomedical research and therapeutics development. Cell culture involves growing living cells in a specially formulated growth media under controlled conditions and has various ... Read More
-
Global Gene Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031
... immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors ... Read More
-
Global Hemophilia Gene Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031
... two types of hemophilia caused by mutations in genes that encode protein factors which help the blood clot and stop bleeding when blood vessels are injured. Individuals with hemophilia experience bleeding episodes after injuries and ... Read More
Research Assistance
